Drug reaction with eosinophilia and systemic symptoms syndrome in association with novel antineoplastic pharmacotherapy: Characterizing reported clinical patterns and outcomes utilizing the Food and Drug Administration Adverse Event Reporting System database
J Am Acad Dermatol. 2025 Sep 15:S0190-9622(25)02807-5.
doi: 10.1016/j.jaad.2025.09.023.
Online ahead of print.
1 Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey. Electronic address: am2792@rwjms.rutgers.edu.
2 Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey.
3 Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey; Department of Dermatology, Weill Cornell School of Medicine, New York, New York.